%PDF-1.4 %
114 0 obj
>
endobj
116 0 obj
>stream
2019-12-09T12:54:16-05:002019-12-18T19:02:47-08:002019-12-18T19:02:47-08:00itext-paulo-155 (itextpdf.sf.net-lowagie.com)application/pdf<alt></p> <li xml:lang="x-default">Intratumoral plasmid IL-12 electroporation therapy in advanced melanoma patients induces systemic and intratumoral T cell responses</li> <p> </alt>uuid:0e4742c4-1dd2-11b2-0a00-bb0827bda400uuid:0e4742c7-1dd2-11b2-0a00-5c0000000000
endstream
endobj
107 0 obj
>
endobj
1 0 obj
>
endobj
117 0 obj
>
endobj
118 0 obj
>
endobj
119 0 obj
>
endobj
12 0 obj
>/MediaBox[0 0 612 792]/Parent 119 0 R/Resources>/ProcSet[/PDF/Text]>>/StructParents 11/Tabs/S/Type/Page>>
endobj
13 0 obj
>/MediaBox[0 0 612 792]/Parent 119 0 R/Resources>/ProcSet[/PDF/Text]>>/StructParents 12/Tabs/S/Type/Page>>
endobj
14 0 obj
>/MediaBox[0 0 612 792]/Parent 119 0 R/Resources>/ProcSet[/PDF/Text]>>/StructParents 13/Tabs/S/Type/Page>>
endobj
15 0 obj
>/MediaBox[0 0 612 792]/Parent 119 0 R/Resources>/Font>/ProcSet[/PDF/Text]>>/StructParents 14/Tabs/S/Type/Page>>
endobj
16 0 obj
>/MediaBox[0 0 612 792]/Parent 119 0 R/Resources>/ProcSet[/PDF/Text]>>/StructParents 15/Tabs/S/Type/Page>>
endobj
17 0 obj
>/MediaBox[0 0 612 792]/Parent 119 0 R/Resources>/Font>/ProcSet[/PDF/Text]>>/StructParents 18/Tabs/S/Type/Page>>
endobj
18 0 obj
>/MediaBox[0 0 612 792]/Parent 119 0 R/Resources>/Font>/ProcSet[/PDF/Text]>>/StructParents 19/Tabs/S/Type/Page>>
endobj
19 0 obj
>/MediaBox[0 0 612 792]/Parent 119 0 R/Resources>/Font>/ProcSet[/PDF/Text]>>/StructParents 24/Tabs/S/Type/Page>>
endobj
20 0 obj
>/MediaBox[0 0 612 792]/Parent 119 0 R/Resources>/Font>/ProcSet[/PDF/Text]>>/StructParents 25/Tabs/S/Type/Page>>
endobj
21 0 obj
>/ProcSet[/PDF/Text/ImageC]/XObject>>>/Type/Page>>
endobj
22 0 obj
>/ProcSet[/PDF/Text/ImageC]/XObject>>>/Type/Page>>
endobj
23 0 obj
>/ProcSet[/PDF/Text/ImageC]/XObject>>>/Type/Page>>
endobj
24 0 obj
>/ProcSet[/PDF/Text/ImageC]/XObject>>>/Type/Page>>
endobj
25 0 obj
>/ProcSet[/PDF/Text/ImageC]/XObject>>>/Type/Page>>
endobj
120 0 obj
>/ProcSet[/PDF/Text/ImageC]/XObject>>>/Type/Page>>
endobj
160 0 obj
[166 0 R 167 0 R 168 0 R 169 0 R 170 0 R 171 0 R]
endobj
161 0 obj
>stream
q
544.9595032 0 0 67.551178 33.5202484 676.448822 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 128.68973 559.99982 Tm
( Published OnlineFirst December 18, 2019.)Tj
/T1_1 1 Tf
-9.66897 0 Td
(Cancer Immunol Res240)Tj
/T1_0 1 Tf
0 1 TD
(240 )Tj
0 1.00001 TD
(Samantha K. Greaney, Alain P Algazi, Katy K Tsai, et al. )Tj
/T1_2 1 Tf
0 1 TD
(240 )Tj
/T1_3 1 Tf
18 0 0 18 32 599.99994 Tm
(responses)Tj
T*
(melanoma patients induces systemic and intratumoral T cell )Tj
T*
(Intratumoral plasmid IL-12 electroporation therapy in advanced)Tj
ET
32 439 548 101 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 122.94202 512.99997 Tm
(240 )Tj
/T1_3 1 Tf
-7.55696 1 Td
(Updated version)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 143 504.99994 Tm
(240 )Tj
/T1_0 1 Tf
16.28698 1 Td
( )Tj
0 0 1 rg
-14.67498 0 Td
(10.1158/2326-6066.CIR-19-0359)Tj
0 g
-1.612 0 Td
(doi:)Tj
0 1.00001 TD
(Access the most recent version of this article at:)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 122.94202 471.99994 Tm
(240 )Tj
/T1_3 1 Tf
-3.50099 1 Td
(Material)Tj
-3.44499 1.00001 Td
(Supplementary)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 143 474.99994 Tm
(240 )Tj
/T1_0 1 Tf
42.96392 1 Td
( )Tj
0 0 1 rg
-42.96392 0 Td
(cancerimmunolres.aacrjournals.org/content/suppl/2019/12/18/2326-6 066.CIR-19-0359.DC1)Tj
0 g
T*
(Access the most recent supplemental material at:)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 122.94202 438.99994 Tm
(240 )Tj
/T1_3 1 Tf
-5.05597 1 Td
(Manuscript)Tj
2.05699 1.00001 Td
(Author)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 143 451.99997 Tm
(edited. )Tj
0 1 TD
(Author manuscripts have been peer reviewed and accepted for publication but have not yet been)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 32 418.99997 Tm
(240 )Tj
T*
(240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 32 398.99997 Tm
(240 )Tj
T*
(240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 32 378.99997 Tm
(240 )Tj
T*
(240 )Tj
ET
32 264 548 115 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 122.94202 346.99997 Tm
(240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(E-mail alerts)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 297.49969 359 Tm
( related to this article or journal.)Tj
0 0 1 rg
-15.44997 0 Td
(Sign up to receive free email-alerts)Tj
ET
BT
0 g
/T1_0 1 Tf
11 0 0 11 122.94202 313.99994 Tm
(240 )Tj
/T1_3 1 Tf
-6.38997 1 Td
(Subscriptions)Tj
0.556 1.00001 Td
(Reprints and )Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 143 316.99994 Tm
(240 )Tj
13.46497 1 Td
(.)Tj
0 0 1 rg
-6.85098 0 Td
([email protected])Tj
0 g
-6.61399 0 Td
(Department at)Tj
0 1.00001 TD
(To order reprints of this article or to subscribe to the journal, contac t the AACR Publications)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 122.94202 291.99997 Tm
(240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(Permissions)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 143 263.99988 Tm
(240 )Tj
0 1 TD
(Rightslink site. )Tj
0 1.00001 TD
(Click on "Request Permissions" which will take you to the Copyright Clea rance Center's (CCC))Tj
40.46291 1 Td
(.)Tj
0 0 1 rg
-40.46291 0 Td
(cancerimmunolres.aacrjournals.org/content/early/2019/12/18/2326-6 066.CIR-19-0359)Tj
0 g
0 1 TD
(To request permission to re-use all or part of this article, use this li nk)Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 261.6514 11 Tm
(on December 18, 2019. 251 2019 American Association for Cancer Research . )Tj
0 0 1 rg
-15.89294 0 Td
(cancerimmunolres.aacrjournals.org )Tj
0 g
-8.11399 0 Td
(Downloaded from )Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 96.63571 769.99997 Tm
(Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. )Tj
0.08551 1 Td
(Author Manuscript Published OnlineFirst on December 18, 2019; DOI: 10.11 58/2326-6066.CIR-19-0359 )Tj
ET

endstream
endobj
165 0 obj
>/Filter/FlateDecode/Height 193/Length 77582/Name/X/Subtype/Image/Type/XObject/Width 1557>>stream
HϋVs?BJR0PbpS*bAlmRǕi8.D:՚ %4N팝y̙g.y=yc{o



Source link